M J Biopharm Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 13.01 Cr
- Company Age 37 Year, 7 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 89.62 Cr
- Revenue Growth 8.69%
- Profit Growth -27.31%
- Ebitda -26.76%
- Net Worth 9.47%
- Total Assets 10.76%
About M J Biopharm
M J Biopharm Private Limited (MJBPL) is Amalgamated company established on 24 Aug 1987 with its office registered at Mumbai, Maharashtra, India and has been running since 37 Year, 7 Months with a paid up capital of 13.01 Cr. According to MCA records, 2 Directors are linked to this company as of 16 Jan 2025.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U29249MH1987PTC044458
- Company No.
044458
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 1987
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
What products or services does M J Biopharm Private Limited offer?
M J Biopharm Private Limited offers a wide range of products and services, including Pharmaceutical Services, Biotechnology Services.
Who are the key members and board of directors at M J Biopharm?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Shah  | Managing Director | 03-Dec-1997 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhaval Vashi | Director | 22-Jun-2013 | Current |
Financial Performance of M J Biopharm.
M J Biopharm Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 8.69% increase. The company also saw a substantial fall in profitability, with a 27.31% decrease in profit. The company's net worth moved up by a moderate rise of 9.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M J Biopharm?
In 2017, M J Biopharm had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eris M. J. Biopharm Private LimitedAmol Shah is a mutual person
Camlin Fine Sciences LimitedAmol Shah is a mutual person
Fine Aroma Specialities Private LimitedAmol Shah is a mutual person
- Fine Fragrances Private Limited
Amol Shah is a mutual person
Fine Aromatics And Herbal Extracts Private LimitedAmol Shah is a mutual person
- M. J. Biopharm Private Limited
Amol Shah and Dhaval Vashi are mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹89.62 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 51.12 Cr
- Abn Amro Bank N. V. : 33.00 Cr
- Export-Import Bank Of India : 5.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jan 2009 | Abn Amro Bank N. V. | ₹14.50 Cr | Satisfied |
| 25 Jun 2007 | Abn Amro Bank N. V. | ₹18.50 Cr | Satisfied |
| 17 Aug 2006 | Export-Import Bank Of India | ₹5.50 Cr | Satisfied |
| 28 May 2003 | Canara Bank | ₹3.50 M | Satisfied |
| 12 Mar 2001 | Canara Bank | ₹0.29 M | Satisfied |
How Many Employees Work at M J Biopharm?
M J Biopharm has a workforce of 264 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M J Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M J Biopharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on M J Biopharm
Recent activity within the organization
- Annual General Meeting
M J Biopharm Private Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records.
- Balance Sheet
M J Biopharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai.
- Charges
A charge registered on 15 Jan 2009 via Charge ID 10137160 with Abn Amro Bank N. V. was fully satisfied on 06 May 2014.
- Charges
A charge registered on 25 Jun 2007 via Charge ID 10058726 with Abn Amro Bank N. V. was fully satisfied on 06 May 2014.
- Director Appointment
Dhaval Vipin Vashi was appointed as a Director was appointed as a Director on 22 Jun 2013 & has been associated with this company since 11 years 9 months .
- Charges
A charge registered on 17 Aug 2006 via Charge ID 10014306 with Export-Import Bank Of India was fully satisfied on 29 Aug 2012.
Recent News, Updates & Announcement
Cousins Reunite in Business: Mehli Mistry Invests in MJ Biopharm for Diabetes Treatment.When your cousin gets kicked out of Tata Group but you still got his back and invest in MJ Biopharm, a company that makes insulin. Mehli Mistry, Cyrus' cousin, bought a 20% stake in the company through his own business. He's also invested in PNB MetLife insurance and his own company, M Pallonji & Co, is doing well. He's interested in MJ Biopharm because he's diabetic. The company makes other drugs too and has two factories. The diabetes market in India is worth a lot. Mehli and Cyrus used to be cool but then Cyrus wanted to be fair and transparent with contracts and Mehli didn't like that. But they both deny any drama..
Frequently asked questions
What is the Incorporation or founding date of M J Biopharm Private Limited?
M J Biopharm Private Limited was incorporated on 24 Aug 1987.
What is authorized share capital and paid-up capital of M J Biopharm Private Limited?
The authorized share capital of M J Biopharm Private Limited is ₹ 20.00 Cr and paid-up capital is ₹ 13.01 Cr.
Who are the current board members & directors of M J Biopharm Private Limited?
Currently 2 directors are associated with M J Biopharm Private Limited.
- Amol Jashvant Shah
- Dhaval Vipin Vashi
What is the registered address of M J Biopharm Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of M J Biopharm Private Limited is 113 Jolly Maker Chambers 2Nariman Point India, Mumbai, Maharashtra, 400021.
What is the corporate identification number (CIN) and company number of M J Biopharm Private Limited?
The corporate identification number (CIN) of M J Biopharm Private Limited is U29249MH1987PTC044458 and the company number is 044458 as per Ministry of Corporate Affairs (MCA).
What is the official website of M J Biopharm Private Limited?
The Official website of M J Biopharm Private Limited is https://www.mjbiopharm.com
What has been the recent revenue trend for M J Biopharm Private Limited?
According to the financial reports for the fiscal year 2017, the revenue trend for M J Biopharm Private Limited has risen by 8.69%.
How many employees does M J Biopharm Private Limited currently have?
As Per 2017 financial reports, 264 employees are currently employed by M J Biopharm Private Limited.
What change has been observed in the net worth of M J Biopharm Private Limited, and by what percentage?
The financial reports for the fiscal year 2017 indicates that The net worth of M J Biopharm Private Limited has experienced an upsurge of 9.47%.
When was the last Balance Sheet of M J Biopharm Private Limited filed with the ROC?
The most recent Balance Sheet for M J Biopharm Private Limited was filed with the ROC on 31 Mar 2017.
People also Viewed
Indravadan JoshiDirectorPS
Pradyumn ShrotriyaDirectorJS
Jashvant ShahAlternate DirectorSM
Shekhar MandrekarAlternate DirectorJB
Joanna BulskaDirectorAP
Adam PolonekDirector